Evidence map›Paper›PMID 30869022›Full record

ArticleEpidemiology and infection2019

Measles and rubella seroprevalence in a population of young adult blood donors, France 2013.

D Antona, P Morel, C Jacquot, L Fonteneau, J Dina, C Vauloup-Fellous, L Gimeno, A Degeorges, P Gallian, D Lévy-Bruhl

Open access · hybridAbstract read
In one paragraph

Article in Epidemiology and infection, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020
    Article
  4. [Seroprevalence of antibodies against measles virus in Galicia: trends during the last ten years depending on age and sex].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2020
    Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

D AntonaDirection des maladies infectieuses,Santé publique France,Saint-Maurice,France.ORCID 0000-0001-5344-7787
P MorelEtablissement Français du Sang,Paris,France.
C JacquotEtablissement Français du Sang,Paris,France.
L FonteneauDirection des maladies infectieuses,Santé publique France,Saint-Maurice,France.
J DinaNormandie Univ, UNICAEN, GRAM EA2556, 14032 France National Reference Center for Measles, Mumps and Rubella, CHU Caen, Virology Department,Caen 14000,France.
C Vauloup-FellousDepartment of Virology,AP-HP, Hôpital Paul Brousse, WHO Rubella NRL, Paris-Sud Univ,INSERM U1193, Villejuif 94804,France.
L GimenoEtablissement Français du Sang,Paris,France.
A DegeorgesEtablissement Français du Sang,Paris,France.
P GallianEtablissement Français du Sang Alpes Méditerranée,Marseille,France.
D Lévy-BruhlDirection des maladies infectieuses,Santé publique France,Saint-Maurice,France.
Établissement Français du Sang · FRSanté Publique France · FRNormandie Université · FRUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As part of the evaluation of the French plan for the elimination of measles and rubella, we conducted a seroprevalence survey in 2013, aimed at updating seroprevalence data for people 18-32 years old. A secondary objective was to estimate measles incidence in this population during the 2009-2011 outbreak, and thus estimate the exhaustiveness of measles mandatory reporting. We used a cross-sectional survey design, targeting blood donors 18-32 years old, living in France since 2009, who came to give blood in a blood collecting site. We included 4647 people in metropolitan France, 806 people in Réunion Island and 496 in the French Caribbean. A further 3942 individuals were interviewed in the south-east region of metropolitan France to estimate the exhaustiveness of measles mandatory reporting. One of the main findings of this survey is that the proportion of people 18-32 years old susceptible to both measles and rubella infections remained high in France in 2013, 9.2% and 5.4%, respectively, in metropolitan France, even after the promotion campaigns about vaccination catch-up during and following the major measles epidemic in 2009-2011. Applying our results to French census data would suggest that around 1 million people aged 18-32 years old are currently susceptible to measles in France, despite this age group being one of the vaccination targets of the national measles elimination plan. Another important finding is that only an estimated 45% of the true number of cases in this age group was actually notified, despite notification being mandatory.

Indexed as

Disease OutbreaksAdultBlood DonorsDisease SusceptibilityFranceHumansIncidenceMeaslesPrevalenceRubellaSeroepidemiologic StudiesYoung AdultFrancemeasles (rubeola)rubellaseroprevalence

Identifiers

PMID30869022
PMCPMC6518532
OpenAlexW2919564618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.